{"entity":{"type":"insider","cik":"0001591874","url":"/insider/0001591874","json_url":"/insider/0001591874.json","name":"Giannasca Paul","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":4,"first":"2014-08-29","last":"2014-09-15","span_basis":"filed_date"},"name_variants":[{"name":"Giannasca Paul","source":"filing","n_filings":4,"first_seen":"2014-08-29","last_seen":"2014-09-15"}],"transactions":[{"id":6854374,"accession":"0000904454-14-000643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000643","line_url":"/filing/0000904454-14-000643#line-2","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4071.0,"shares_display":"4,071","price_per_share":11.84,"price_display":"11.84","price_state":"stated","total_value":48200.64,"total_display":"48,200.64","total_whole":"48,201","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-11","filed_date":"2014-09-15","scope":"insider"},{"id":6891243,"accession":"0000904454-14-000627","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-14-000627","line_url":"/filing/0000904454-14-000627#line-6","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":834.0,"shares_display":"834","price_per_share":12.35,"price_display":"12.35","price_state":"stated","total_value":10299.9,"total_display":"10,299.90","total_whole":"10,300","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-10","filed_date":"2014-09-10","scope":"insider"},{"id":6891228,"accession":"0000904454-14-000627","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-14-000627","line_url":"/filing/0000904454-14-000627#line-4","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2455.0,"shares_display":"2,455","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":30515.65,"total_display":"30,515.65","total_whole":"30,516","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-09","filed_date":"2014-09-10","scope":"insider"},{"id":6891221,"accession":"0000904454-14-000627","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000627","line_url":"/filing/0000904454-14-000627#line-2","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2970.0,"shares_display":"2,970","price_per_share":12.8,"price_display":"12.80","price_state":"stated","total_value":38016.0,"total_display":"38,016.00","total_whole":"38,016","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-08","filed_date":"2014-09-10","scope":"insider"},{"id":6453206,"accession":"0000904454-14-000619","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000619","line_url":"/filing/0000904454-14-000619#line-2","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5398.0,"shares_display":"5,398","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":67528.98,"total_display":"67,528.98","total_whole":"67,529","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-02","filed_date":"2014-09-04","scope":"insider"},{"id":6247896,"accession":"0000904454-14-000608","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-14-000608","line_url":"/filing/0000904454-14-000608#line-6","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":855.0,"shares_display":"855","price_per_share":12.86,"price_display":"12.86","price_state":"stated","total_value":10995.3,"total_display":"10,995.30","total_whole":"10,995","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-29","filed_date":"2014-08-29","scope":"insider"},{"id":6247891,"accession":"0000904454-14-000608","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000904454-14-000608","line_url":"/filing/0000904454-14-000608#line-4","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4602.0,"shares_display":"4,602","price_per_share":12.36,"price_display":"12.36","price_state":"stated","total_value":56880.72,"total_display":"56,880.72","total_whole":"56,881","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-28","filed_date":"2014-08-29","scope":"insider"},{"id":6247886,"accession":"0000904454-14-000608","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-14-000608","line_url":"/filing/0000904454-14-000608#line-2","is_derivative":false,"issuer_cik":"0001457612","issuer_name":"GENOCEA BIOSCIENCES, INC.","issuer_ticker":"GNCA","issuer_name_source":null,"issuer_url":"/issuer/0001457612","owner_cik":"0001591874","owner_name":"Giannasca Paul","owner_display_name":"Giannasca Paul","owner_url":"/insider/0001591874","role":"Officer (VP of Development)","role_mark":"O","role_mark_label":"Officer (VP of Development)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP of Development","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1303.0,"shares_display":"1,303","price_per_share":12.77,"price_display":"12.77","price_state":"stated","total_value":16639.31,"total_display":"16,639.31","total_whole":"16,639","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":8,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":8},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001457612","name":"GENOCEA BIOSCIENCES, INC.","url":"/issuer/0001457612","role":"Officer (VP of Development)","n_filings":4,"first_seen":"2014-08-29","last_seen":"2014-09-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001591874","retrieved_at":"2026-08-25T01:59:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}